ID: ALA5286993

Max Phase: Preclinical

Molecular Formula: C20H20ClN3O2

Molecular Weight: 369.85

Associated Items:

Representations

Canonical SMILES:  CN(C)CCNC(=O)c1cc(Oc2ccccc2)nc2ccc(Cl)cc12

Standard InChI:  InChI=1S/C20H20ClN3O2/c1-24(2)11-10-22-20(25)17-13-19(26-15-6-4-3-5-7-15)23-18-9-8-14(21)12-16(17)18/h3-9,12-13H,10-11H2,1-2H3,(H,22,25)

Standard InChI Key:  ZANQYDVXRDCGDW-UHFFFAOYSA-N

Associated Targets(non-human)

enterovirus D68 324 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 369.85Molecular Weight (Monoisotopic): 369.1244AlogP: 3.97#Rotatable Bonds: 6
Polar Surface Area: 54.46Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.51CX LogP: 3.92CX LogD: 2.78
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.71Np Likeness Score: -1.62

References

1. Kaur R, Kumar K..  (2021)  Synthetic and medicinal perspective of quinolines as antiviral agents.,  215  [PMID:33609889] [10.1016/j.ejmech.2021.113220]

Source